Brief Description
Dahlia Biosciences is leading the development of cell-based RNA detection tools using CRISPR technology. The foundational RNA-targeting Cas9 technology was invented by Dr. Mitchell O’Connell and Dr. Sam Sternberg in the laboratory of Dr. Jennifer Doudna at UC Berkeley.
The company's vision is to empower scientists to study and isolate cells at high resolution via sensitive, robust, and multiplexed RNA detection in both fixed and live cells.
Timeline
- 2011. Company founded
Inventors
Jennifer Doudna, Mitchell O'Connell, Benjamin Oakes, Samuel Sternberg